Joseph K M Li1, Peter K F Chiu1, Chi-Fai Ng2. 1. SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong. 2. SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong. ngcf@surgery.cuhk.edu.hk.
Abstract
OBJECTIVE: The term microbiome is used to signify the ecological community of commensal, symbiotic, and pathogenic microorganisms that share our body space, in which there were increasing evidences to suggest that they might have potential roles in various medical conditions. While the study of microbiome in the urinary system is not as robust as the systems included in the Human Microbiome Project, there are still evidences in the literature showing that microbiome may have a role in urological diseases. Therefore, we would like to perform a systematic review on the topic and summarize the available evidence on the impact of microbiome on urological diseases. METHODOLOGY: This review was performed according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement. After screening 589 abstracts and including additional studies (such as references from review papers), 76 studies were included for review and discussion. RESULTS: Studies had suggested that there were correlations of microbiome of different body cavities (e.g., fecal, urinary and seminal fluid) with urological diseases. Also, different diseases would have different microbiome profile in different body cavities. Unfortunately, the studies on the association of microbiome and urological diseases were still either weak or inconsistent. CONCLUSION: Studies suggested that there might be some relationship between microbiome and various urological diseases. However, further large-scale studies with control of confounding factors should be performed under a standardized methodology in order to have better understanding of the relationship. Also, more standardized reporting protocol for microbiome studies should be considered for better communications in future studies.
OBJECTIVE: The term microbiome is used to signify the ecological community of commensal, symbiotic, and pathogenic microorganisms that share our body space, in which there were increasing evidences to suggest that they might have potential roles in various medical conditions. While the study of microbiome in the urinary system is not as robust as the systems included in the Human Microbiome Project, there are still evidences in the literature showing that microbiome may have a role in urological diseases. Therefore, we would like to perform a systematic review on the topic and summarize the available evidence on the impact of microbiome on urological diseases. METHODOLOGY: This review was performed according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement. After screening 589 abstracts and including additional studies (such as references from review papers), 76 studies were included for review and discussion. RESULTS: Studies had suggested that there were correlations of microbiome of different body cavities (e.g., fecal, urinary and seminal fluid) with urological diseases. Also, different diseases would have different microbiome profile in different body cavities. Unfortunately, the studies on the association of microbiome and urological diseases were still either weak or inconsistent. CONCLUSION: Studies suggested that there might be some relationship between microbiome and various urological diseases. However, further large-scale studies with control of confounding factors should be performed under a standardized methodology in order to have better understanding of the relationship. Also, more standardized reporting protocol for microbiome studies should be considered for better communications in future studies.
Authors: Reet Mändar; Margus Punab; Paul Korrovits; Silver Türk; Kristo Ausmees; Eleri Lapp; Jens-Konrad Preem; Kristjan Oopkaup; Andres Salumets; Jaak Truu Journal: Int J Urol Date: 2017-02-01 Impact factor: 3.369
Authors: Cynthia S Fok; Xiang Gao; Huaiying Lin; Krystal J Thomas-White; Elizabeth R Mueller; Alan J Wolfe; Qunfeng Dong; Linda Brubaker Journal: Int Urogynecol J Date: 2018-08-16 Impact factor: 2.894
Authors: V Gutierrez Millet; M Praga; B Miranda; I Bello; L Ruilope; R Diaz Gonzalez; O Leyva; J M Alcazar; A Barrientos; J L Rodicio Journal: J Urol Date: 1985-03 Impact factor: 7.450
Authors: Robert J Motzer; Bernard Escudier; David F McDermott; Saby George; Hans J Hammers; Sandhya Srinivas; Scott S Tykodi; Jeffrey A Sosman; Giuseppe Procopio; Elizabeth R Plimack; Daniel Castellano; Toni K Choueiri; Howard Gurney; Frede Donskov; Petri Bono; John Wagstaff; Thomas C Gauler; Takeshi Ueda; Yoshihiko Tomita; Fabio A Schutz; Christian Kollmannsberger; James Larkin; Alain Ravaud; Jason S Simon; Li-An Xu; Ian M Waxman; Padmanee Sharma Journal: N Engl J Med Date: 2015-09-25 Impact factor: 91.245
Authors: Daniel A Shoskes; Hannah Wang; Alan S Polackwich; Barbara Tucky; Jessica Altemus; Charis Eng Journal: J Urol Date: 2016-02-27 Impact factor: 7.450
Authors: J Curtis Nickel; Alisa Stephens; J Richard Landis; Chris Mullins; Adrie van Bokhoven; M Scott Lucia; Garth D Ehrlich Journal: J Urol Date: 2015-09-26 Impact factor: 7.450
Authors: Meghan M Pearce; Evann E Hilt; Amy B Rosenfeld; Michael J Zilliox; Krystal Thomas-White; Cynthia Fok; Stephanie Kliethermes; Paul C Schreckenberger; Linda Brubaker; Xiaowu Gai; Alan J Wolfe Journal: MBio Date: 2014-07-08 Impact factor: 7.867
Authors: Tiffany Wang; Colleen S Kraft; Michael H Woodworth; Tanvi Dhere; Molly E Eaton Journal: Open Forum Infect Dis Date: 2018-01-15 Impact factor: 3.835